Blog

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…

CertaraMay 10, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

CertaraMay 24, 2023

Conference

ACoP 2026

CertaraMay 24, 2023

Conference

Asembia AXS26 Summit

–

CertaraFebruary 15, 2023

Conference

ISPOR International Annual Conference 2026

–

CertaraFebruary 15, 2023

Conference

2026 ACCP Annual Meeting

–

CertaraJuly 15, 2022

Conference

ASCPT 2026 Annual Meeting

CertaraMarch 7, 2022

Publication

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Perhaps the most important lesson learned from the COVID‐19 pandemic is that of preparedness. Enhanced…

CertaraMay 11, 2021

Drug Development

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

American College of Toxicology 2026 Annual Meeting

ACoP 2026

Asembia AXS26 Summit

ISPOR International Annual Conference 2026

2026 ACCP Annual Meeting

ASCPT 2026 Annual Meeting

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Newsletter sign up

Quick links

Solutions

Contact